Table 1.
Demographic and clinical information on study participants
| Variables | VL Group (n = 48) | ASY Group (n = 47) | EC Group (n = 59) |
|---|---|---|---|
| Age, years | |||
| Mean ± SD | 27.94 ± 14.54 | 36.26 ± 16.10 | 34.78 ± 10.29 |
| Median | 24.5 | 38 | 33 |
| Sex, no. | |||
| Male | 31 | 18 | 32 |
| Female | 17 | 29 | 27 |
| Illness duration, days | |||
| Mean ± SD | 26.65 ± 15.23 | NA | NA |
| Median | 28 | NA | NA |
| Haemoglobin level, mg mL−1 | |||
| Before treatment | |||
| Mean ± SD | 9.2 ± 1.60 | ND | ND |
| Median | 9.3 | ND | ND |
| WBC, ×103 cells mm−3 | |||
| D‐0 | |||
| Mean ± SD | 4854.83 ± 3676.85 | ND | ND |
| Median | 4150 | ND | ND |
| Splenic enlargement, cm | |||
| D‐0 | |||
| Mean ± SD | 4.08 ± 2.88 | NA | NA |
| Median | 3 | NA | NA |
ND, Assay not done.